These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 3085983
1. Enzyme-linked immunoabsorbant assay of apolipoprotein AII in plasma, with use of a monoclonal antibody. Stein EA, DiPersio L, Pesce AJ, Kashyap M, Kao JT, Srivastava L, McNerney C. Clin Chem; 1986 Jun; 32(6):967-71. PubMed ID: 3085983 [Abstract] [Full Text] [Related]
2. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function. Kempen HJ, van Gent CM, Buytenhek R, Buis B. J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880 [Abstract] [Full Text] [Related]
3. Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels. James RW, Proudfoot A, Pometta D. Biochim Biophys Acta; 1989 Apr 26; 1002(3):292-301. PubMed ID: 2469471 [Abstract] [Full Text] [Related]
4. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia. Saku K, Gartside PS, Hynd BA, Mendoza SG, Kashyap ML. Metabolism; 1985 Aug 26; 34(8):754-64. PubMed ID: 3927110 [Abstract] [Full Text] [Related]
5. Expression of the human serum apolipoprotein AI and AII genes in Xenopus laevis oocytes. Lipid-associated secretion of gene products. Haase A, Stoffel W. Biol Chem Hoppe Seyler; 1988 Jul 26; 369(7):585-93. PubMed ID: 2852015 [Abstract] [Full Text] [Related]
6. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma. Nichols AV, Blanche PJ, Shore VG, Gong EL. Biochim Biophys Acta; 1989 Feb 20; 1001(3):325-37. PubMed ID: 2492827 [Abstract] [Full Text] [Related]
7. Characterization of high density lipoprotein binding to human adipocyte plasma membranes. Fong BS, Rodrigues PO, Salter AM, Yip BP, Despres JP, Angel A, Gregg RE. J Clin Invest; 1985 Jun 20; 75(6):1804-12. PubMed ID: 2989332 [Abstract] [Full Text] [Related]
8. Characterization of two monoclonal antibodies to human apolipoprotein A-I that also bind to rabbit apolipoprotein A-I. Application to ELISA evaluation of rabbit serum apo A-I. Leroy A, Olivier P, Vu-Dac N, Fruchart JC. Clin Chim Acta; 1989 Jan 13; 179(1):85-95. PubMed ID: 2493349 [Abstract] [Full Text] [Related]
9. Mechanism of action of gemfibrozil on lipoprotein metabolism. Saku K, Gartside PS, Hynd BA, Kashyap ML. J Clin Invest; 1985 May 13; 75(5):1702-12. PubMed ID: 3923042 [Abstract] [Full Text] [Related]
10. Immunochemical characterization of apolipoprotein A-I from normal human plasma. In vitro modification of apo A-I antigens. Milthorp P, Weech PK, Milne RW, Marcel YL. Arteriosclerosis; 1986 May 13; 6(3):285-96. PubMed ID: 3085646 [Abstract] [Full Text] [Related]
11. HDL metabolism in HDL deficiency associated with familial hypertriglyceridemia: effect of treatment with gemfibrozil. Kashyap ML, Saku K. Adv Exp Med Biol; 1991 May 13; 285():233-6. PubMed ID: 1907081 [Abstract] [Full Text] [Related]
12. Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1. Greilberger J, Jürgens G. Biochem J; 1998 Apr 01; 331 ( Pt 1)(Pt 1):185-91. PubMed ID: 9512478 [Abstract] [Full Text] [Related]
13. Competitive enzyme inhibition immunoassay of apolipoprotein A-I: use of monoclonal antibodies. Bekaert ED, Ayrault-Jarrier M, Petit E, Betourne C, Robin H, Polonovski J. Clin Chem; 1988 Jun 01; 34(6):1030-5. PubMed ID: 2454166 [Abstract] [Full Text] [Related]
14. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Clin Chem; 1990 Aug 01; 36(8 Pt 1):1431-5. PubMed ID: 2117505 [Abstract] [Full Text] [Related]
15. High-density lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria. Saku K, Mendoza SG, Laver M, Hynd BA, Gartside PS, Kashyap ML. Nephron; 1988 Aug 01; 50(2):112-5. PubMed ID: 3146703 [Abstract] [Full Text] [Related]
16. Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films. Marcel YL, Weech PK, Nguyen TD, Milne RW, McConathy WJ. Eur J Biochem; 1984 Sep 17; 143(3):467-76. PubMed ID: 6479161 [Abstract] [Full Text] [Related]
17. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma. Cheung MC, Wolf AC, Illingworth DR. Biochim Biophys Acta; 1992 Oct 30; 1128(2-3):244-9. PubMed ID: 1420297 [Abstract] [Full Text] [Related]
18. [Quantitative determination of apolipoprotein AI in serum by the use of monoclonal antibodies in a noncompetitive ELISA]. Winkler L, Müller DW, Dargel R, Jäger L. Z Med Lab Diagn; 1990 Oct 30; 31(3):159-64. PubMed ID: 2114707 [Abstract] [Full Text] [Related]
19. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Displacement of SAA from the HDL-SAA complex by apo AI and apo AII. Husebekk A, Skogen B, Husby G. Scand J Immunol; 1987 Apr 30; 25(4):375-81. PubMed ID: 3107118 [Abstract] [Full Text] [Related]
20. Identification and characterization of apolipoprotein(AII-E2-AII) complex in human plasma lipoprotein. Tozuka M, Hidaka H, Miyachi M, Furihata K, Katsuyama T, Kanai M. Biochim Biophys Acta; 1992 Nov 11; 1165(1):61-7. PubMed ID: 1420349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]